Revance Therapeutics Inc (NASDAQ:RVNC)

12.24
Delayed Data
As of 4:00pm ET
 -0.54 / -4.23%
Today’s Change
11.65
Today|||52-Week Range
33.83
-25.00%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close12.78
Today’s open12.74
Day’s range12.06 - 12.80
Volume84,285
Average volume (3 months)701,794
Market cap$1.0B
Data as of 4:00pm ET, 05/25/2022

Growth & Valuation

Earnings growth (last year)+14.31%
Earnings growth (this year)+9.72%
Earnings growth (next 5 years)+192.00%
Revenue growth (last year)+407.65%
P/E ratioNM
Price/Sales14.16
Price/Book14.34

Competitors

----
----
RETAReata Pharmaceutical...-0.20-0.74%
AMRXAmneal Pharmaceutica...+0.13+3.94%
Data as of 4:00pm ET, 05/25/2022

Financials

Next reporting dateAugust 4, 2022
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$77.8M
Annual profit (last year)-$281.3M
Net profit margin-361.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Nashville, Tennessee

Forecasts